The Future of Oncology Trials: Innovation & Genomic Profiling in Australia March 10th, 2021


Join the conversation with Susan Cole, George Clinical’s Global Head Therapeutic Strategy, Oncology, and Prof. David Thomas of the Garvan Institute of Medical Research, covering the future of oncology trials and genomic profiling.

Genomic profiling is changing cancer medicine, enabling mapping of the mutational circuitry of cancers. Dozens of highly effective therapies have changed treatment options for many cancers and have received regulatory approval. This evolution has driven the development of large-scale genomic profiling programs linked to biomarker-dependent therapeutic trials.

In Australia, a national precision oncology platform to enable large-scale genomic screening of cancer patients has been developed through an innovative non-profit company, Omico. George Clinical’s collaboration with Omico looks to harness the paradigm-shifting potential of this platform to change the way how oncology trials are conducted in Australia.

The webinar will also address:

  • An introduction to the Omico platform
  • Economic hurdles that can impact the way diagnostic algorithms and a standard of care are implemented
  • The potential of genomic profiling to revolutionize clinical trial access to and for patients
  • Operational barriers faced in the implementation of oncology trials and how these could be surpassed with a platform such as Omico


George Clinical's Leadership in Attendance

Susan Cole

  • Regional Head Project Operations USA & Europe / Global Head Therapeutic Strategy, Oncology

Susan is responsible for U.S. project and clinical operations, including project management, study startup, monitoring and site management services. With over 25 years in clinical research, she brings experience in all phases of clinical trials, multiple therapeutic areas including over 12 years in oncology, and key leadership roles in clinical operations and financial management. She has helped develop or improve services for multiple U.S. Contract Research and Site Management organizations, as well as a national oncology site network. Her work with global and cross-functional teams brings added value to the George Clinical team as the Global Head of Therapeutic Strategy, Oncology.

Event Location

Zoom Webinar

Attending this event?

Meet with George Clinical! Contact us to schedule a time now.

    I agree to the handling of my personal information in accordance with the George Clinical privacy policy.

    Please input this code: captcha

    Add George Clinical to your network